We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.65%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$19.3B
AUM Growth
+$276M
(+1.5%)
Cap. Flow
-$864M
Cap. Flow
% of AUM
-4.48%
Top 10 Holdings %
Top 10 Hldgs %
44.33%
Holding
252
New
9
Increased
38
Reduced
113
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$6.63M |
| 2 |
Enterprise Products Partners
EPD
|
+$4.91M |
| 3 |
Southwest Airlines
LUV
|
+$2.98M |
| 4 |
Wynn Resorts
WYNN
|
+$925K |
| 5 |
Blackstone
BX
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$89.2M |
| 2 |
Altria Group
MO
|
+$51.7M |
| 3 |
Philip Morris
PM
|
+$46.8M |
| 4 |
Apple
AAPL
|
+$46.8M |
| 5 |
ExxonMobil
XOM
|
+$30.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.2% |
| 2 | Financials | 18.48% |
| 3 | Energy | 15.07% |
| 4 | Technology | 10.96% |
| 5 | Healthcare | 9.52% |
Similar funds
HF
Fayez Sarofim & Co's Q4 2017 Portfolio in Review
As of Q4 2017, Fayez Sarofim & Co held 252 positions worth $19.3B, up 1.5% from $19B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Fayez Sarofim & Co withdrew a net $864M in Q4 2017, closing 4 positions and reducing 113 holdings. Its most notable exit was Celgene Corp, an estimated $89.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, down from 30% a quarter earlier, followed by Financials and Energy.
Against the trend, Fayez Sarofim & Co opened a new position in Blackstone worth $879K.
- Fayez Sarofim & Co's largest Q4 2017 buy was Blackstone: 27,466 shares worth $879K.
- Fayez Sarofim & Co added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $6.63M increase.
- Fayez Sarofim & Co's biggest Q4 2017 reduction was Altria Group, cutting an estimated $51.7M.
- Fayez Sarofim & Co fully exited Celgene Corp in Q4 2017, selling an estimated $89.2M.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $19.3B portfolio in Q4 2017.
- Fayez Sarofim & Co opened 9 new positions and closed 4 in Q4 2017.
- Fayez Sarofim & Co's portfolio value rose 1.5% quarter-over-quarter to $19.3B.
Based on Fayez Sarofim & Co's 13F filing for Q4 2017, filed 13 Feb 2018.